Shanghai Shyndec Pharmaceutical Statistics
Total Valuation
Shanghai Shyndec Pharmaceutical has a market cap or net worth of CNY 17.27 billion. The enterprise value is 14.88 billion.
Market Cap | 17.27B |
Enterprise Value | 14.88B |
Important Dates
The last earnings date was Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Sep 20, 2024 |
Share Statistics
Shanghai Shyndec Pharmaceutical has 1.34 billion shares outstanding. The number of shares has increased by 9.07% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.34B |
Shares Change (YoY) | +9.07% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 1.31% |
Owned by Institutions (%) | 9.35% |
Float | 542.49M |
Valuation Ratios
The trailing PE ratio is 15.96 and the forward PE ratio is 12.88. Shanghai Shyndec Pharmaceutical's PEG ratio is 0.42.
PE Ratio | 15.96 |
Forward PE | 12.88 |
PS Ratio | 1.50 |
PB Ratio | 1.32 |
P/TBV Ratio | n/a |
P/FCF Ratio | 8.49 |
P/OCF Ratio | n/a |
PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.41, with an EV/FCF ratio of 7.31.
EV / Earnings | 13.75 |
EV / Sales | 1.29 |
EV / EBITDA | 6.41 |
EV / EBIT | 9.72 |
EV / FCF | 7.31 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.07.
Current Ratio | 2.51 |
Quick Ratio | 1.61 |
Debt / Equity | 0.07 |
Debt / EBITDA | 0.49 |
Debt / FCF | 0.56 |
Interest Coverage | 40.65 |
Financial Efficiency
Return on equity (ROE) is 9.30% and return on invested capital (ROIC) is 6.04%.
Return on Equity (ROE) | 9.30% |
Return on Assets (ROA) | 4.89% |
Return on Capital (ROIC) | 6.04% |
Revenue Per Employee | 990,814 |
Profits Per Employee | 93,253 |
Employee Count | 11,608 |
Asset Turnover | 0.59 |
Inventory Turnover | 3.09 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.21% in the last 52 weeks. The beta is 0.21, so Shanghai Shyndec Pharmaceutical's price volatility has been lower than the market average.
Beta (5Y) | 0.21 |
52-Week Price Change | +24.21% |
50-Day Moving Average | 11.68 |
200-Day Moving Average | 10.78 |
Relative Strength Index (RSI) | 61.65 |
Average Volume (20 Days) | 26,043,468 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Shyndec Pharmaceutical had revenue of CNY 11.50 billion and earned 1.08 billion in profits. Earnings per share was 0.81.
Revenue | 11.50B |
Gross Profit | 4.38B |
Operating Income | 1.53B |
Pretax Income | 1.63B |
Net Income | 1.08B |
EBITDA | 2.31B |
EBIT | 1.53B |
Earnings Per Share (EPS) | 0.81 |
Balance Sheet
The company has 5.64 billion in cash and 1.13 billion in debt, giving a net cash position of 4.51 billion or 3.36 per share.
Cash & Cash Equivalents | 5.64B |
Total Debt | 1.13B |
Net Cash | 4.51B |
Net Cash Per Share | 3.36 |
Equity (Book Value) | 15.19B |
Book Value Per Share | 9.75 |
Working Capital | 6.98B |
Cash Flow
In the last 12 months, operating cash flow was 2.30 billion and capital expenditures -264.53 million, giving a free cash flow of 2.04 billion.
Operating Cash Flow | 2.30B |
Capital Expenditures | -264.53M |
Free Cash Flow | 2.04B |
FCF Per Share | 1.52 |
Margins
Gross margin is 38.09%, with operating and profit margins of 13.31% and 9.41%.
Gross Margin | 38.09% |
Operating Margin | 13.31% |
Pretax Margin | 14.15% |
Profit Margin | 9.41% |
EBITDA Margin | 20.05% |
EBIT Margin | 13.31% |
FCF Margin | 17.70% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.55%.
Dividend Per Share | 0.20 |
Dividend Yield | 1.55% |
Dividend Growth (YoY) | 100.00% |
Years of Dividend Growth | n/a |
Payout Ratio | 21.82% |
Buyback Yield | -9.07% |
Shareholder Yield | -7.52% |
Earnings Yield | 6.27% |
FCF Yield | 11.78% |
Stock Splits
The last stock split was on May 25, 2017. It was a forward split with a ratio of 2.
Last Split Date | May 25, 2017 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Shanghai Shyndec Pharmaceutical has an Altman Z-Score of 3.41.
Altman Z-Score | 3.41 |
Piotroski F-Score | n/a |